Top Markets
#1 Akedo Akedo +146.29%
#2 TENDIES TENDIES +96.27%
#3 Threshold Network Threshold Network +47.05%
#4 Verus Coin Verus Coin +43.84%
#5 Mubarak Mubarak +27.69%
#6 Bitway Bitway +26.92%
#7 MultiversX MultiversX +23.94%
#8 Palladium Network Palladium Network +22.69%
#9 Cash Cat Cash Cat +22.59%
#10 aelf aelf +19.17%
Coin of the day
Akedo Akedo
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Shukra Pharmaceuticals Limited Shukra Pharmaceuticals Limited

Shukra Pharmaceuticals Limited

SHUKRAPHAR
Rang in Aktien #17792
Shukra Pharmaceuticals Limited is a prominent company engaged in the... Shukra Pharmaceuticals Limited is a prominent company engaged in the manufacturing and global distribution of pharmaceutical products. Their comprehensive product line addresses a broad spectrum of medical conditions, encompassing anti-infective medications (such as antibiotics, macrolides, quinolones, antivirals, antifungals, antimalarials, antiprotozoals, and anti-helminthics), central nervous system drugs (including sedatives, tranquilizers, antidepressants, and anti-manic agents), gastrointestinal treatments (like anti-emetics and anti-ulcer drugs), cardiovascular remedies (beta-blockers, diuretics), pain and inflammation management (analgesics, muscle relaxants, corticosteroids), anti-tuberculosis drugs, vitamin supplements, anti-allergy medications, and therapies for metabolic imbalances such as hyper- and hypoglycemia. The company was established on March 4, 1993, and its primary operations are directed from its headquarters in Ahmedabad, India.
Aktienkurs
$0.51647906
Marktkapitalisierung
$226.16M
Veränderung (1 Tag)
5.29%
Veränderung (1 Jahr)
66.66%
Land
IN
Handel Shukra Pharmaceuticals Limited (SHUKRAPHAR)

Kategorie

Healthcare
Dividendenrendite-Verlauf für Shukra Pharmaceuticals Limited (SHUKRAPHAR)
Dividendenrendite (TTM) von Shukra Pharmaceuticals Limited (Aktienkürzel: SHUKRAPHAR) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Shukra Pharmaceuticals Limited (SHUKRAPHAR) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
1.51%
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
0.00%
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
0.00%
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
0.00%
IT
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
1.89%
HK